Oral News and Research

RSS

Overactivity of EGFR protein leads to heightened cancer growth and chemotherapy resistance

Overactivity of a protein that normally cues cells to divide sabotages the body-s natural cellular recycling process, leading to heightened cancer growth and chemotherapy resistance, UT Southwestern Medical Center researchers have found.

19 Sep 2013

Nanodiamonds could be used to promote bone growth and durability of dental implants

UCLA researchers have discovered that diamonds on a much, much smaller scale than those used in jewelry could be used to promote bone growth and the durability of dental implants.

19 Sep 2013

Researchers discover new way to combat HIV-1 infection

Current drug treatments for HIV work well to keep patients from developing AIDS, but no one has found a way to entirely eliminate the virus from the human body, so patients continue to require lifelong treatment to prevent them from developing AIDS.

19 Sep 2013

Doctoral thesis sheds light on phenomenon of war rape in DRC

Rape in war cannot be addressed in isolation. It is deeply embedded in both the local context and that of global proportions. This is one of the conclusions made in a doctoral thesis about eastern Democratic Republic of Congo presented at Uppsala University, Sweden, on 19th September.

18 Sep 2013

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

Boehringer Ingelheim and Eli Lilly and Company today announced they will feature five oral and 12 poster presentations for linagliptin and the investigational compound empagliflozin* at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) which will take place in Barcelona, from 23 – 27 September. The presentations will add to the already existing body of data on safety and efficacy of these two compounds.

18 Sep 2013

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy.

18 Sep 2013

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.

17 Sep 2013

Basketball player with rapid heart rhythm successfully treated using minimally invasive procedure

Brainna McCormick was warming up for a high school basketball game last December when she noticed something wasn't right. An accomplished athlete, McCormick knows her body so when her heart started racing she knew something was wrong.

13 Sep 2013

New report shows 6.6 million children under 5 died in 2012

In 2012, approximately 6.6 million children worldwide - 18 000 children per day - died before reaching their fifth birthday, according to a new report released today by UNICEF, WHO, the World Bank Group and the United Nations Department of Economic and Social Affairs/Population Division. This is roughly half the number of under-fives who died in 1990, when more than 12 million children died.

13 Sep 2013

Nanodiamonds deliver chemotherapy directly into brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed an innovative drug-delivery system in which tiny particles called nanodiamonds are used to carry chemotherapy drugs directly into brain tumors.

13 Sep 2013

Microbiologist finds breakthrough herbal medicine treatment for common human fungal pathogen

A Kansas State University microbiologist has found a breakthrough herbal medicine treatment for a common human fungal pathogen that lives in almost 80 percent of people.

13 Sep 2013

Scientists uncover how bacterium responsible for periodontal disease worsens RA

Does gum disease indicate future joint problems? Although researchers and clinicians have long known about an association between two prevalent chronic inflammatory diseases - periodontal disease and rheumatoid arthritis - the microbiological mechanisms have remained unclear.

13 Sep 2013

New Aspen Dental office opens in Venice, FL

A new Aspen Dental office is opening in Venice, FL on Thursday, September 12. Located at 4246 S. Tamiami Trail, the practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

12 Sep 2013

Study finds low doses of vancomycin to be effective in treating serious C-difficile infection

Clostridium difficile infection (CDI) treatment in a hospital setting using low dose oral vancomycin showed similar effectiveness compared to high dose, according to a new study by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University.

12 Sep 2013

Aspen Dental celebrates first location in Texas

Aspen Dental celebrates its first location in Texas on Thursday, September 12 with the opening of a new practice at 6109 Highway 191 in Odessa. The new office in Texas means that Aspen Dental dentists and staff now proudly serve communities in 27 states across the country.

12 Sep 2013

Research shows smoking and obesity together may pose triple health threat

Millions of people who are obese and smoke tobacco may face additional health problems — including their responses to common prescription medicines — that extend beyond the well-known links with cancer, heart attacks and stroke, according to a report presented here today.

12 Sep 2013

Ventana gets CFDA approval for VENTANA ALK immunohistochemistry assay

Ventana Medical Systems, Inc., a member of the Roche Group, today announced the approval of the VENTANA ALK immunohistochemistry assay by the Chinese Food and Drug Administration as a companion diagnostic to aid in the identification of patients for Pfizer's CFDA-approved oncology product XALKORI (crizotinib).

12 Sep 2013

Breckenridge acquires Cypress Pharmaceutical product assets from Pernix Therapeutics

Breckenridge Pharmaceutical, Inc. announced today that it has completed its acquisition of certain Cypress Pharmaceutical, Inc. product assets from Pernix Therapeutics. The assets include 11 Abbreviated New Drug Applications filed with the FDA, certain ANDAs in various stages of development, as well as 6 already-approved and marketed products.

12 Sep 2013

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

...

11 Sep 2013

Scientists use nanodiamonds to boost delivery of drug to leukemic cells

By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug to leukemic cells and retain the drug within the cells to combat the cancer.

11 Sep 2013

Oral News and Research

Overactivity of EGFR protein leads to heightened cancer growth and chemotherapy resistance

Nanodiamonds could be used to promote bone growth and durability of dental implants

Researchers discover new way to combat HIV-1 infection

Doctoral thesis sheds light on phenomenon of war rape in DRC

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

VBP15 drug shows early promise for treatment of Duchenne muscular dystrophy

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

Basketball player with rapid heart rhythm successfully treated using minimally invasive procedure

New report shows 6.6 million children under 5 died in 2012

Nanodiamonds deliver chemotherapy directly into brain tumors

Microbiologist finds breakthrough herbal medicine treatment for common human fungal pathogen

Scientists uncover how bacterium responsible for periodontal disease worsens RA

New Aspen Dental office opens in Venice, FL

Study finds low doses of vancomycin to be effective in treating serious C-difficile infection

Aspen Dental celebrates first location in Texas

Research shows smoking and obesity together may pose triple health threat

Ventana gets CFDA approval for VENTANA ALK immunohistochemistry assay

Breckenridge acquires Cypress Pharmaceutical product assets from Pernix Therapeutics

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

Scientists use nanodiamonds to boost delivery of drug to leukemic cells

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News